Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
BACKGROUND: Neuropsychiatric symptoms (NPS) are the leading cause of the social burden of dementia but their role is underestimated.
BACKGROUND: The widespread incidence and prevalence of Alzheimer's disease and mild cognitive impairment (MCI) has prompted an urgent call for research to validate early detection cognitive screening and assessment.
BACKGROUND: Currently, there is no objective, clinically available tool for the accurate diagnosis of Alzheimer's disease (AD). There is a pressing ne...
BACKGROUND: Language is a valuable source of clinical information in Alzheimer's disease, as it declines concurrently with neurodegeneration. Conseque...
BACKGROUND: In recent years, accumulating evidence has linked vitamin D deficiency to cognitive dysfunction and dementia. This study aimed at determin...
Rivastigmine is a non-competitive reversible inhibitor of acetylcholinesterase which is approved as one of the fi rst-line treatment options for Alzhe...
Alzheimer's disease (AD) is a typical neurodegenerative disease, which is clinically manifested as amnesia, loss of language ability and self-care abi...
PURPOSE: To evaluate random forests (RFs) as a supervised machine learning algorithm to classify amyloid brain PET as positive or negative for amyloid...
A novel data-based machine learning algorithm for predicting amyloid aggregation rates is reported in this paper. Based on a highly nonlinear projecti...
BACKGROUND: The development of diagnostic and prognostic tools for Alzheimer disease is complicated by substantial clinical heterogeneity in prodromal...
The current study focuses on the short-term effect of MARIO, a social robot, on quality of life, depression, and perceived social support in persons w...
Artificial intelligence (AI) shows promises in terms of diagnostic support on neuroimaging. We developed a software that predicts Alzheimer's disease ...
Using AI for dementia diagnosis is still in research stage, however some of the work points to the development of new medical devices. One is a voxel-...
For patients with dementia and their family, artificial intelligence (AI) has been utilized to support diagnosis and evaluation. In addition, communic...
Alzheimer's disease significantly affects the quality of life of patients. This paper proposes an approach to identify Alzheimer's disease based on tr...
Early prediction of diseased brain conditions is critical for curing illness and preventing irreversible neuronal dysfunction and loss. Generically re...
Ultrasound (US) is a valuable imaging modality used to detect primary breast malignancy. However, radiologists have a limited ability to distinguish b...
Due to both the hidden nature and the irreversibility of Alzheimers disease (AD), it has become the killer of the elderly and is thus the focus of muc...
Alzheimer's disease (AD) is characterized by gradual neurodegeneration and loss of brain function, especially for memory during early stages. Regressi...
A crucial quest in neuroimaging is the discovery of image features (biomarkers) associated with neurodegenerative disorders. Recent works show that su...